Serum cholinesterase is an early and sensitive marker of graft-versus host-disease (GVHD) and transplant-related mortality (TRM)

Bone Marrow Transplantation

Volumn 28, Issue 11, 2001, Pages 1041-1045

  Bacigalupo, A ^a   Oneto, R ^a   Bruno, B ^a   Lamparelli, T ^a   Gualandi, F ^a   Bregante, S ^a   Raiola, A M ^a   Di Grazia, C ^a   Dominietto, A ^a   Lombardi, A ^a   Frassoni, F ^a   Van Lint, M T ^a  

^a UNIVERSITY OF GENOA   (Italy)

Author keywords

GVHD; Serum cholinesterase; Transplant related mortality

Indexed keywords

BIOLOGICAL MARKER; CHOLINESTERASE;

ACUTE DISEASE; ADOLESCENT; ADULT; AGED; ALLOGRAFT; ARTICLE; CHOLINESTERASE BLOOD LEVEL; CONTROLLED STUDY; CORRELATION FUNCTION; DISEASE MARKER; DONOR; FEMALE; GRAFT VERSUS HOST REACTION; HLA TYPING; HUMAN; ISOGRAFT; LIVER CIRRHOSIS; LIVER FUNCTION; MAJOR CLINICAL STUDY; MALE; POSTOPERATIVE COMPLICATION; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; RECIPIENT; RELAPSE; RELIABILITY; SCORING SYSTEM; SENSITIVITY AND SPECIFICITY; SIBLING; STEM CELL TRANSPLANTATION; SURGICAL MORTALITY; SURVIVAL; TREATMENT OUTCOME; TWINS;

ADOLESCENT; ADULT; AGED; BIOLOGICAL MARKERS; CHOLINESTERASES; FEMALE; GRAFT VS HOST DISEASE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HISTOCOMPATIBILITY TESTING; HLA ANTIGENS; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NUCLEAR FAMILY; PROPORTIONAL HAZARDS MODELS; RECURRENCE; SENSITIVITY AND SPECIFICITY; TRANSPLANTATION, HOMOLOGOUS;

EID: 0035659907     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1703281     Document Type: Article

References (16)

1. Organophosphorus poisons: Anticholinesterases and related compounds
2. Prognostic evaluation of patients with parenchymal cirrhosis: Proposal of a new simple score
3. Evaluation of hepatic function in liver cirrosis: Clinical utility of galactose elimination capacity, hepatic clarence of D-sorbitol and laboratory investigations
4. The role of hepatitis C and B virus infections as risk factors for severe liver complications following allogeneic BMT: A prospective study by the infectious disease Working Party of the European Blood and Marrow Transplantation Group
5. Veno-occlusive disease of the liver: Development of a model for predicting fatal outcome after marrow transplantation
6. Clinical manifestations of acute graft-versus-host disease in human recipients of marrow from HLA-matched sibling donors
7. Early predictors of transplant-related mortality (TRM) after allogeneic bone marrow transplants (BMT): Blood urea nitrogen (BUN) and bilirubin
8. Non parametric estimation from incomplete observations
9. Factors influencing hematologic recovery after allogeneic hemopoietic stem cells transplant (HSCT): Graft-versus-host disease, donor type, cytomegalovirus infections and cell dose
10. IBMTR Severity Index for grading acute graft-versus-host disease: Retrospective comparison with Glucksberg grade
11. The clinical diagnosis of acute graft-versus-host disease: A diversity of views amongst marrow transplant centers
12. Reproducibility in retrospective grading of acute graft-versus-host disease after allogeneic marrow transplantation
13. Donor lymphocyte infusions (DLI) in patients with chronic myeloid leukemia following allogeneic bone marrow transplantation
14. Toxicity and efficacy of 409 donor lymphocyte infusions for treatment of relapse after allogeneic bone marrow transplantation
15. Changes in serum diamine oxidase activity during chemotherapy in patients with hematological malignancies
16. Regression of metastatic renal cell carcinoma after nonmyeloablative allogeneic peripheral-blood stem cell transplantation